Hyderabad, July 6 (RAHNUMA): Minister for IT and Industries Duddilla Sridhar Babu said the Telangana government is transforming the state into a world-class life sciences innovation hub by leveraging the rapid advancements taking place in the healthcare sector.
He stated that the government is building a comprehensive ecosystem by integrating research, technology, artificial intelligence (AI), advanced manufacturing, and skill development to address future healthcare challenges.
The Minister formally inaugurated India’s first integrated oncology manufacturing facility, established by Ciro Pharma Private Limited with an investment of ₹800 crore at Biotech Park Phase-III in Karakapatla, Markook Mandal, Siddipet district on Monday.
Speaking on the occasion, Sridhar Babu said the government is committed to making Telangana a role model for industrial development in the country. He announced that a special action plan has been prepared to develop the Zaheerabad National Investment and Manufacturing Zone (NIMZ) into a model manufacturing zone.
The Minister reiterated the government’s commitment to promoting Green Pharma in the state. Keeping future generations in mind, the government is encouraging industries to adopt environmentally sustainable pharmaceutical manufacturing practices. He expressed hope that the next breakthrough pharmaceutical molecule with global impact would be discovered in Telangana and assured full government support toward achieving that goal.
He said the Telangana Rising–2047 vision and the Next Generation Life Sciences Policy aim to create an integrated ecosystem connecting every stage of the value chain from research to manufacturing. As part of this strategy, the government is prioritising cutting-edge sectors such as biologics, biosimilars, cell and gene therapies, AI, and digital health, he said.
Sridhar Babu alleged that the opposition is deliberately spreading misinformation about the government’s flagship initiatives, including Bharat Future City and the HILT Policy. He claimed that unable to accept Telangana’s industrial achievements over the past two and a half years, opposition parties are attempting to mislead the public through false propaganda.
The newly inaugurated facility will manufacture oral oncology medicines, sterile injectables, lyophilized powder injections, and soft gel capsules using advanced containment technology for cancer treatment. The plant is expected to generate 500 direct jobs initially, with employment likely to double in the coming years.
The Minister expressed confidence that the facility would strengthen India’s pharmaceutical manufacturing capabilities while further reinforcing Telangana’s position as a global life sciences hub.
The event was attended by Revenue, Housing and Information & Public Relations Minister Ponguleti Srinivasa Reddy, company representatives Dr. Govinda Reddy, Dr. Madhusudan Reddy, and other dignitaries.
